2009 | CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2014 | Clinical Usefulness of 18F-Fluorodeoxyglucose-Positron Emission Tomography in Patients With Locally Advanced Pancreatic Cancer Planned to Undergo Concurrent Chemoradiation Therapy | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2006 | Concurrent chemoradiotherapy with doxifluridine and paclitaxel for extrahepatic bile duct cancer | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2014 | Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2014 | Full-dose gemcitabine is a more effective chemotherapeutic agent than 5-fluorouracil for concurrent chemoradiotherapy as first-line treatment in locally advanced pancreatic cancer | CHEMOTHERAPY |
2013 | Gastrointestinal hemorrhage after concurrent chemoradiotherapy in locally advanced pancreatic cancer
| GUT AND LIVER |
2013 | Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer | PANCREATOLOGY |
2012 | High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2012 | Pancreatoduodenectomy following neoadjuvant chemoradiation therapy in uncinate process pancreatic cancer. | PANCREAS |
2015 | Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
| MEDICINE |
2009 | Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy | RADIOLOGY |
2009 | Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | JOURNAL OF GASTROINTESTINAL SURGERY |
2016 | Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer.
| PLOS ONE |
2014 | Validation of Group B Borderline Resectable Pancreatic Cancer: Retrospective Analysis
| GUT AND LIVER |
2008 | Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer
| BRITISH JOURNAL OF CANCER |
2007 | 동시 항암화학-방사선요법 후 근치적 절제술을 시행한 진행성 위암종 1례-F-39-
| Korean Journal of Medicine |
2009 | 수술전 S1과 cisplatin 병합 동시 항암화학-방사선요법 후 병리학적 완전관해를 확인한 진행성 위암 1예
| Korean Journal of Medicine |
1994 | 악성종양에 의한 폐쇄성황달 및 폐쇄 상하부에 담관결석이 동반된 환자에서 Coil형 팽창성금속도관(Endocoil) 삽관을 통한 치료
| Korean Journal of Gastrointestinal Endoscopy(대한소화기내시경학회지) |
2002 | 절제 불가능한 췌장암의 동시항암화학방사선요법
| Journal of the Korean Society for Therapeutic Radiology and Oncology |